FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387537097> ?p ?o ?g. }

• W4387537097 abstract "Abstract Background Spindle and kinetochore-associated complex subunit 3 (SKA3) plays an important role in cell proliferation by regulating the separation of chromosomes and their division into daughter cells. Previous studies demonstrated that SKA3 was strongly implicated in tumor development and progression. However, the roles of SKA3 in cholangiocarcinoma (CCA) and the underlying mechanisms remain unclear. Methods Next-generation sequencing (NGS) was performed with paired CCA tissues and normal adjacent tissues (NATs). SKA3 was chose to be the target gene because of its remarkably upregulation and unknown function in cholangiocarcinoma in TCGA datasets, GSE107943 datasets and our sequencing results. RT-PCR and immunohistochemistry staining were used to detect the expression of SKA3 in paired CCA tissues and normal adjacent tissues. The SKA3 knockdown and overexpression cell line were constructed by small interfering RNA and lentivirus vector transfection. The effect of SKA3 on the proliferation of cholangiocarcinoma under hypoxic conditions was detected by experiments in vitro and in vivo. RNA-seq was used to find out the differentially expressed pathways in cholangiocarcinoma proliferation under hypoxia regulated by SKA3. IP/MS analysis and Western blot assays were used to explore the specific mechanism of SKA3 in regulating the expression of HIF-1a under hypoxia. Results SKA3 was up-regulated in NGS, TCGA and GSE107943 databases and was associated with poor prognosis. Functional experiments in vitro and in vivo showed that hypoxia-induced SKA3 promoted cholangiocarcinoma cell proliferation. RNA-sequencing was performed and verified that SKA3 enhanced fatty acid synthesis by up-regulating the expression of key fatty acid synthase, thus promoting cholangiocarcinoma cell proliferation under hypoxic conditions. Further studies indicated that under hypoxic conditions, SKA3 recruited PARP1 to bind to HIF-1a, thus enhancing the poly ADP-ribosylation (PARylation) of HIF-1a. This PARylation enhanced the binding between HIF-1a and USP7, which triggered the deubiquitylation of HIF-1a under hypoxic conditions. Additionally, PARP1 and HIF-1a were upregulated in CCA and promoted CCA cell proliferation. SKA3 promoted CCA cell proliferation and fatty acid synthesis via the PARP1/HIF-1a axis under hypoxic conditions. High SKA3 and HIF-1a expression levels were associated with poor prognosis after surgery. Conclusion Hypoxia-induced SKA3 promoted CCA progression by enhancing fatty acid synthesis via the regulation of PARylation-dependent HIF-1a deubiquitylation. Furthermore, increased SKA3 level enhanced chemotherapy-resistance to gemcitabine-based regimen under hypoxic conditions. SKA3 and HIF-1a could be potential oncogenes and significant biomarkers for the analysis of CCA patient prognosis." @default.
• W4387537097 created "2023-10-12" @default.
• W4387537097 creator A5006101921 @default.
• W4387537097 creator A5006241552 @default.
• W4387537097 creator A5006282634 @default.
• W4387537097 creator A5012732014 @default.
• W4387537097 creator A5017578886 @default.
• W4387537097 creator A5035262071 @default.
• W4387537097 creator A5036398018 @default.
• W4387537097 creator A5045392886 @default.
• W4387537097 creator A5049781553 @default.
• W4387537097 creator A5067341415 @default.
• W4387537097 creator A5069875119 @default.
• W4387537097 creator A5072860571 @default.
• W4387537097 creator A5076637933 @default.
• W4387537097 creator A5085560837 @default.
• W4387537097 creator A5089117918 @default.
• W4387537097 date "2023-10-11" @default.
• W4387537097 modified "2023-10-14" @default.
• W4387537097 title "Hypoxia-induced SKA3 promoted cholangiocarcinoma progression and chemoresistance by enhancing fatty acid synthesis via the regulation of PAR-dependent HIF-1a deubiquitylation" @default.
• W4387537097 cites W1749022239 @default.
• W4387537097 cites W1804986381 @default.
• W4387537097 cites W1965006127 @default.
• W4387537097 cites W1968994392 @default.
• W4387537097 cites W1970744454 @default.
• W4387537097 cites W1972032694 @default.
• W4387537097 cites W1979313505 @default.
• W4387537097 cites W1988902633 @default.
• W4387537097 cites W1989805664 @default.
• W4387537097 cites W2006124751 @default.
• W4387537097 cites W2014150894 @default.
• W4387537097 cites W2022643257 @default.
• W4387537097 cites W2048548143 @default.
• W4387537097 cites W2052835275 @default.
• W4387537097 cites W2069839376 @default.
• W4387537097 cites W2070895117 @default.
• W4387537097 cites W2079327004 @default.
• W4387537097 cites W2103292784 @default.
• W4387537097 cites W2109819280 @default.
• W4387537097 cites W2133650808 @default.
• W4387537097 cites W2138110344 @default.
• W4387537097 cites W2153178365 @default.
• W4387537097 cites W2260577542 @default.
• W4387537097 cites W2294235052 @default.
• W4387537097 cites W2461760410 @default.
• W4387537097 cites W2466426028 @default.
• W4387537097 cites W2502621236 @default.
• W4387537097 cites W2593205109 @default.
• W4387537097 cites W2747955726 @default.
• W4387537097 cites W2791937016 @default.
• W4387537097 cites W2804573719 @default.
• W4387537097 cites W2849197408 @default.
• W4387537097 cites W2899857300 @default.
• W4387537097 cites W2927532895 @default.
• W4387537097 cites W2938928710 @default.
• W4387537097 cites W2944132034 @default.
• W4387537097 cites W2979410128 @default.
• W4387537097 cites W2993388453 @default.
• W4387537097 cites W3006090213 @default.
• W4387537097 cites W3008946274 @default.
• W4387537097 cites W3009424821 @default.
• W4387537097 cites W3039360174 @default.
• W4387537097 cites W3128360316 @default.
• W4387537097 cites W3132936802 @default.
• W4387537097 cites W3137428078 @default.
• W4387537097 cites W3170840405 @default.
• W4387537097 cites W3195010072 @default.
• W4387537097 cites W3195266229 @default.
• W4387537097 cites W3208931580 @default.
• W4387537097 cites W4327682525 @default.
• W4387537097 doi "https://doi.org/10.1186/s13046-023-02842-7" @default.
• W4387537097 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37821935" @default.
• W4387537097 hasPublicationYear "2023" @default.
• W4387537097 type Work @default.
• W4387537097 citedByCount "0" @default.
• W4387537097 crossrefType "journal-article" @default.
• W4387537097 hasAuthorship W4387537097A5006101921 @default.
• W4387537097 hasAuthorship W4387537097A5006241552 @default.
• W4387537097 hasAuthorship W4387537097A5006282634 @default.
• W4387537097 hasAuthorship W4387537097A5012732014 @default.
• W4387537097 hasAuthorship W4387537097A5017578886 @default.
• W4387537097 hasAuthorship W4387537097A5035262071 @default.
• W4387537097 hasAuthorship W4387537097A5036398018 @default.
• W4387537097 hasAuthorship W4387537097A5045392886 @default.
• W4387537097 hasAuthorship W4387537097A5049781553 @default.
• W4387537097 hasAuthorship W4387537097A5067341415 @default.
• W4387537097 hasAuthorship W4387537097A5069875119 @default.
• W4387537097 hasAuthorship W4387537097A5072860571 @default.
• W4387537097 hasAuthorship W4387537097A5076637933 @default.
• W4387537097 hasAuthorship W4387537097A5085560837 @default.
• W4387537097 hasAuthorship W4387537097A5089117918 @default.
• W4387537097 hasBestOaLocation W43875370971 @default.
• W4387537097 hasConcept C104317684 @default.
• W4387537097 hasConcept C127561419 @default.
• W4387537097 hasConcept C153911025 @default.
• W4387537097 hasConcept C173396325 @default.
• W4387537097 hasConcept C178790620 @default.
• W4387537097 hasConcept C185592680 @default.
• W4387537097 hasConcept C190283241 @default.
• W4387537097 hasConcept C22615655 @default.

• next